These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 7602142)

  • 1. Measuring interactions of MHC class I molecules using surface plasmon resonance.
    Khilko SN; Jelonek MT; Corr M; Boyd LF; Bothwell AL; Margulies DH
    J Immunol Methods; 1995 Jun; 183(1):77-94. PubMed ID: 7602142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct detection of major histocompatibility complex class I binding to antigenic peptides using surface plasmon resonance. Peptide immobilization and characterization of binding specificity.
    Khilko SN; Corr M; Boyd LF; Lees A; Inman JK; Margulies DH
    J Biol Chem; 1993 Jul; 268(21):15425-34. PubMed ID: 8393442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of MHC-CD8 interaction at the T cell membrane.
    Huang J; Edwards LJ; Evavold BD; Zhu C
    J Immunol; 2007 Dec; 179(11):7653-62. PubMed ID: 18025211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studying interactions involving the T-cell antigen receptor by surface plasmon resonance.
    Margulies DH; Plaksin D; Khilko SN; Jelonek MT
    Curr Opin Immunol; 1996 Apr; 8(2):262-70. PubMed ID: 8725950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Participation of L3T4 in T cell activation in the absence of class II major histocompatibility complex antigens. Inhibition by anti-L3T4 antibodies is a function both of epitope density and mode of presentation of anti-receptor antibody.
    Owens T; Fazekas de St Groth B
    J Immunol; 1987 Apr; 138(8):2402-9. PubMed ID: 2435798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell receptor-MHC class I peptide interactions: affinity, kinetics, and specificity.
    Corr M; Slanetz AE; Boyd LF; Jelonek MT; Khilko S; al-Ramadi BK; Kim YS; Maher SE; Bothwell AL; Margulies DH
    Science; 1994 Aug; 265(5174):946-9. PubMed ID: 8052850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MHC class I/peptide interactions: binding specificity and kinetics.
    Margulies DH; Corr M; Boyd LF; Khilko SN
    J Mol Recognit; 1993 Jun; 6(2):59-69. PubMed ID: 8305252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Affinity and kinetics of the interactions between an alphabeta T-cell receptor and its superantigen and class II-MHC/peptide ligands.
    Khandekar SS; Brauer PP; Naylor JW; Chang HC; Kern P; Newcomb JR; Leclair KP; Stump HS; Bettencourt BM; Kawasaki E; Banerji J; Profy AT; Jones B
    Mol Immunol; 1997 Apr; 34(6):493-503. PubMed ID: 9307065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of bispecific heteroconjugated antibodies (anti-T cell antigen receptor x anti-MHC class II) to study activation of T cells with a full length or truncated antigen receptor zeta-chain.
    Wu S; Yang Y; Sadegh-Nasseri S; Ashwell JD
    J Immunol; 1993 Mar; 150(6):2211-21. PubMed ID: 8450208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.
    Schirrmacher V; Schild HJ; Gückel B; von Hoegen P
    Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():311-26. PubMed ID: 7901150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4 and CD8 accessory molecules function through interactions with major histocompatibility complex molecules which are not directly associated with the T cell receptor-antigen complex.
    Lustgarten J; Waks T; Eshhar Z
    Eur J Immunol; 1991 Oct; 21(10):2507-15. PubMed ID: 1915555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of T-cell receptor binding to peptide/I-Ek complexes: correlation of the dissociation rate with T-cell responsiveness.
    Matsui K; Boniface JJ; Steffner P; Reay PA; Davis MM
    Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12862-6. PubMed ID: 7809136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of T cells by antigen-presenting cells is kinetically controlled by antigenic peptide binding to major histocompatibility complex class II molecules.
    McConnell HM; Wada HG; Arimilli S; Fok KS; Nag B
    Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2750-4. PubMed ID: 7708718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4-Ia interactions can occur in the absence of T-cell receptor/antigen-Ia recognition.
    Andris F; Leo O; Van Mechelen M; Urbain J; Slaoui M
    Immunology; 1989 Sep; 68(1):1-6. PubMed ID: 2530152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low affinity interaction of peptide-MHC complexes with T cell receptors.
    Matsui K; Boniface JJ; Reay PA; Schild H; Fazekas de St Groth B; Davis MM
    Science; 1991 Dec; 254(5039):1788-91. PubMed ID: 1763329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [MHC tetramers: tracking specific immunity].
    Kosor E; Gagro A; Drazenović V; Kuzman I; Jeren T; Rakusić S; Rabatić S; Markotić A; Gotovac K; Sabioncello A; Cecuk E; Kerhin-Brkljacić V; Gjenero-Margan I; Kaić B; Mlinarić-Galinović G; Kastelan A; Dekaris D
    Acta Med Croatica; 2003; 57(4):255-9. PubMed ID: 14639858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A monoclonal antibody specific for a cytochrome c T cell stimulatory peptide inhibits T cell responses and affects the way the peptide associates with antigen-presenting cells.
    Jemmerson R; Johnson JG; Burrell E; Taylor PS; Jenkins MK
    Eur J Immunol; 1991 Jan; 21(1):143-51. PubMed ID: 1846813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Force-Regulated In Situ TCR-Peptide-Bound MHC Class II Kinetics Determine Functions of CD4+ T Cells.
    Hong J; Persaud SP; Horvath S; Allen PM; Evavold BD; Zhu C
    J Immunol; 2015 Oct; 195(8):3557-64. PubMed ID: 26336148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous presentation of a nascent antigenic epitope to CD8+ CTL is more efficient than exogenous presentation.
    Hahn YS; Hahn CS; Braciale TJ
    Immunol Cell Biol; 1996 Oct; 74(5):394-400. PubMed ID: 8912001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant antibodies with MHC-restricted, peptide-specific, T-cell receptor-like specificity: new tools to study antigen presentation and TCR-peptide-MHC interactions.
    Cohen CJ; Denkberg G; Lev A; Epel M; Reiter Y
    J Mol Recognit; 2003; 16(5):324-32. PubMed ID: 14523945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.